Skip to main content

Discontinued Tests

Tests may be discontinued at short notice for various reasons: the majority of discontinuations relate to change with reagent manufacturers or analyser development, supply chain, suspension or regulatory review, etc. 

Whilst every effort will be made to look for a replacement referral laboratory, an alternative service may not be available, and it may be difficult to replace these infrequently requested tests for the short or long term. Where possible, samples that have been received by TDL will be referred for a similar service. 

The turnaround times, normal values and methodology are, however, likely to be different. If a substitute service cannot be found, you will be notified as it may not always be possible to store samples for the long term. In these instances, it will be necessary to discard or return the sample to the referring service.

 

Test Code Comment

Alpha Fetoprotein on Amniotic fluid

AFPA

Effective 03/11/23

Arabinose

ARBN

Effective 23/04/23

Calreticulin – CALR exon 9 variant screen

CALR

16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel)

Cartilage Antibody

ACA

Effective 23/04/23

Collagen Type 1 Cross-Linked N-Telopeptide – NTX

NTX

Effective 17/11/23

Collagen (Type I, II, IV) Antibodies

COAB

Test no longer available. Effective 01/03/24

Coxsackie IgM or Enterovirus IgM 

COXM

Effective 26/05/23

Endometrial Immune Profiling Biopsy RNA

23RF

Effective 01/02/24. An alternative test Decidualization Score (DS) is available from the same sample type: test code DSRF, TAT 2-3 weeks.

Functional Vitamin B Profile  (B1, B2, B6)

BIOF

Effective 23/04/23

Glutathione – Red Cell

GLUR

Effective 23/04/23

Glutathione Reductase

GRED

Effective 23/04/23

Gut Permeability Profile (With PEG 400)  (Leaky Gut Test)

GPP

Effective 23/04/23

Hair Mineral Analysis

HMA

Effective 23/04/23

Hepcidin

HPDN

Effective 17/05/23

Human Anti-Mouse Ab’s   (To Confirm Presence Of Heterophilic Ab’s)

HAMA

Effective 23/04/23

Inner Ear Antigen

IEA

Temporarily suspended until further notice. 27/10/23

JAK2 – exon 12 sequencing (rare variants)

JE12

16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel)

JAK2 V617F genotyping assay

JAK2

16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel)

KRAS/NRAS screening assay

MGP

12/7/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel)

Kryptopyrroles

KRYP

Effective 23/04/23

LDL7 Subfractions

 

LDL7

Temporarily discontinued until further notice. Contact TDL Referrals Department for an update. Effective 16/02/24

Listeria Antibodies

LIST

Effective 26/05/23

Lutein

LUTE 

Effective 23/04/23

Lycopene

LYCO

Effective 23/04/23

Mannose Binding Lectin

MBL

Effective 11/05/23

Melanin (Urine)

MELA

Effective 23/04/23

MPL exon 10 analysis

MPL

16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel)

Niacin - Blood

NIAC

Effective 23/04/23

NMP22  (Bladder Cancer Marker)

NMP

Replaced by UBC - Urinary Bladder cancer antigen 23/04/23

Noonan Syndrome Prenatal Screen – PTPN11 exons 3 & 11

GENE

Effective 03/11/23

NPM1 mutascreen assay

NPM

16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel)

Pethidine - Urine

UPET

Effective 23/04/23

Poliovirus (Serotypes 1-3) Antibodies By Neutralization

POLO

Effective 17/05/23

Small Intestinal Bacterial Overgrowth Test

SIBO

Effective 23/04/23

T-SPOT®.COVID

TCEL

Effective 04/12/23

Vitamin D2/D3

D2D3

Effective 23/04/23

Ziwig Endotest

ENDT

Temporarily suspended until further notice. 27/10/23

 

Updated Friday, 01 March 2024